Literature DB >> 12515076

Management of submacular hemorrhage.

Matthew T S Tennant1, Jesus L Borrillo, Carl D Regillo.   

Abstract

Submacular hemorrhage is a vision-threatening complication of choroidal and retinal disease. Visual outcome after submacular hemorrhage is dependent on the underlying disease process, amount of subretinal hemorrhage, and duration before treatment. Treatment options include observation, surgical evacuation with or without tissue plasminogen activator (tPA), or pneumatic displacement with or without tPA. The preoperative amount of subretinal hemorrhage may help dictate what treatment modality is chosen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515076     DOI: 10.1016/s0896-1549(02)00049-4

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  9 in total

1.  Severe vitreous hemorrhage associated with closed-globe injury.

Authors:  Ling Yeung; Tun-Lu Chen; Ya-Hui Kuo; An-Ning Chao; Wei-Chi Wu; Kuan-Jen Chen; Yih-Shiou Hwang; Yen- Po Chen; Chi-Chun Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-26       Impact factor: 3.117

2.  [Subretinal hemorrhage. Natural course and staging].

Authors:  S Bopp
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

3.  Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.

Authors:  Makoto Inoue; Fumio Shiraga; Yukari Shirakata; Yuki Morizane; Shuhei Kimura; Akito Hirakata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-25       Impact factor: 3.117

4.  Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane.

Authors:  Manisha Agarwal; S P Chaudhary; Ritesh Narula; Simpy Rajpal
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

5.  Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.

Authors:  R P Singh; C Patel; J E Sears
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

6.  Management of neovascular age-related macular degeneration in clinical practice: initiation, maintenance, and discontinuation of therapy.

Authors:  Pearse A Keane; Adnan Tufail; Praveen J Patel
Journal:  J Ophthalmol       Date:  2011-11-22       Impact factor: 1.909

7.  Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade to Displace Acute Submacular Haemorrhages Secondary to Age-Related Macular Degeneration.

Authors:  Danilo Iannetta; Michele De Maria; Elena Bolletta; Valentina Mastrofilippo; Antonio Moramarco; Luigi Fontana
Journal:  Clin Ophthalmol       Date:  2021-08-28

8.  Author's reply: To PMID 23202390.

Authors:  Ekta Rishi; Lingam Gopal; Pukhraj Rishi; Sabyasachi Sengupta; Tarun Sharma
Journal:  Indian J Ophthalmol       Date:  2013-11       Impact factor: 1.848

9.  Management of significant reactivation of old disciform scars in wet age-related macular degeneration.

Authors:  Rosa M Coco; Anna Sala-Puigdollers
Journal:  BMC Ophthalmol       Date:  2014-06-25       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.